Molecular alterations in Barrett's esophagus and adenocarcinoma

S. Ozawa, N. Ando, Yuukou Kitagawa, M. Ueda, M. Kitajima

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Patients with Barrett's columnar-lined esophagus are at increased risk of developing esophageal adenocarcinoma, the incidence of which has increased rapidly especially in the USA. Although the number of patients with Barrett's adenocarcinoma is fewer in Japan than in the USA, all gastroenterologist should know its multistep carcinogenic process. Tumor suppressor genes (p53, p16), oncogenes (c-erbB-2, H-ras, K-ras, cyclin D1, src), and growth factor/receptor (TGF-alpha, EGFR) seem to cause the malignant transformation of Barrett's esophagus. Because detection of these molecular alterations is feasible, more accurate diagnosis of Barrett's esophageal biopsy specimens should be made by adding the molecular examination to the conventional pathologic examination.

Original languageEnglish
Pages (from-to)235-239
Number of pages5
JournalNippon Geka Gakkai zasshi
Volume100
Issue number3
Publication statusPublished - 1999

Fingerprint

Barrett Esophagus
Adenocarcinoma
Transforming Growth Factor alpha
Growth Factor Receptors
Cyclin D1
Tumor Suppressor Genes
Oncogenes
Esophagus
Japan
Biopsy
Incidence
Gastroenterologists

Cite this

Ozawa, S., Ando, N., Kitagawa, Y., Ueda, M., & Kitajima, M. (1999). Molecular alterations in Barrett's esophagus and adenocarcinoma. Nippon Geka Gakkai zasshi, 100(3), 235-239.

Molecular alterations in Barrett's esophagus and adenocarcinoma. / Ozawa, S.; Ando, N.; Kitagawa, Yuukou; Ueda, M.; Kitajima, M.

In: Nippon Geka Gakkai zasshi, Vol. 100, No. 3, 1999, p. 235-239.

Research output: Contribution to journalArticle

Ozawa, S, Ando, N, Kitagawa, Y, Ueda, M & Kitajima, M 1999, 'Molecular alterations in Barrett's esophagus and adenocarcinoma', Nippon Geka Gakkai zasshi, vol. 100, no. 3, pp. 235-239.
Ozawa, S. ; Ando, N. ; Kitagawa, Yuukou ; Ueda, M. ; Kitajima, M. / Molecular alterations in Barrett's esophagus and adenocarcinoma. In: Nippon Geka Gakkai zasshi. 1999 ; Vol. 100, No. 3. pp. 235-239.
@article{92a5282180ea4c43951154d66a8eaf3b,
title = "Molecular alterations in Barrett's esophagus and adenocarcinoma",
abstract = "Patients with Barrett's columnar-lined esophagus are at increased risk of developing esophageal adenocarcinoma, the incidence of which has increased rapidly especially in the USA. Although the number of patients with Barrett's adenocarcinoma is fewer in Japan than in the USA, all gastroenterologist should know its multistep carcinogenic process. Tumor suppressor genes (p53, p16), oncogenes (c-erbB-2, H-ras, K-ras, cyclin D1, src), and growth factor/receptor (TGF-alpha, EGFR) seem to cause the malignant transformation of Barrett's esophagus. Because detection of these molecular alterations is feasible, more accurate diagnosis of Barrett's esophageal biopsy specimens should be made by adding the molecular examination to the conventional pathologic examination.",
author = "S. Ozawa and N. Ando and Yuukou Kitagawa and M. Ueda and M. Kitajima",
year = "1999",
language = "English",
volume = "100",
pages = "235--239",
journal = "Nihon Geka Gakkai zasshi",
issn = "0301-4894",
publisher = "Nihon Geka Gakkai",
number = "3",

}

TY - JOUR

T1 - Molecular alterations in Barrett's esophagus and adenocarcinoma

AU - Ozawa, S.

AU - Ando, N.

AU - Kitagawa, Yuukou

AU - Ueda, M.

AU - Kitajima, M.

PY - 1999

Y1 - 1999

N2 - Patients with Barrett's columnar-lined esophagus are at increased risk of developing esophageal adenocarcinoma, the incidence of which has increased rapidly especially in the USA. Although the number of patients with Barrett's adenocarcinoma is fewer in Japan than in the USA, all gastroenterologist should know its multistep carcinogenic process. Tumor suppressor genes (p53, p16), oncogenes (c-erbB-2, H-ras, K-ras, cyclin D1, src), and growth factor/receptor (TGF-alpha, EGFR) seem to cause the malignant transformation of Barrett's esophagus. Because detection of these molecular alterations is feasible, more accurate diagnosis of Barrett's esophageal biopsy specimens should be made by adding the molecular examination to the conventional pathologic examination.

AB - Patients with Barrett's columnar-lined esophagus are at increased risk of developing esophageal adenocarcinoma, the incidence of which has increased rapidly especially in the USA. Although the number of patients with Barrett's adenocarcinoma is fewer in Japan than in the USA, all gastroenterologist should know its multistep carcinogenic process. Tumor suppressor genes (p53, p16), oncogenes (c-erbB-2, H-ras, K-ras, cyclin D1, src), and growth factor/receptor (TGF-alpha, EGFR) seem to cause the malignant transformation of Barrett's esophagus. Because detection of these molecular alterations is feasible, more accurate diagnosis of Barrett's esophageal biopsy specimens should be made by adding the molecular examination to the conventional pathologic examination.

UR - http://www.scopus.com/inward/record.url?scp=0033094824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033094824&partnerID=8YFLogxK

M3 - Article

C2 - 10379532

AN - SCOPUS:0033094824

VL - 100

SP - 235

EP - 239

JO - Nihon Geka Gakkai zasshi

JF - Nihon Geka Gakkai zasshi

SN - 0301-4894

IS - 3

ER -